MedTrace Logo

Telavancin Observational Use Registry (TOUR)

NCT02288234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1063

Last updated 2019-01-15

No results posted yet for this study

Summary

The telavancin observational use registry (TOUR) will collect data to support study of the efficacy, safety, and pattern of use of telavancin in hospital-based inpatients and in outpatients being treated in infusion centers who are receiving clinician directed telavancin therapy.

Conditions

  • Hospital Acquired Bacterial Pneumonia
  • Complicated Skin and Skin Structure Infections
  • Ventilator Associated Bacterial Pneumonia
  • Gram Positive Infection

Interventions

DRUG

Vibativ

This is an observational study for patients who were already prescribed Vibativ.

Sponsors & Collaborators

  • Cumberland Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Cumberland Pharmaceuticals, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-06-30
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02288234 on ClinicalTrials.gov